Insights into strategies for optimizing ovarian cancer care
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2015.225.pdf
Reference10 articles.
1. Dottino, J. A., Cliby, W. A., Myers, E. R., Bristow, R. E. & Havrilesky, L. J. Improving NCCN guideline-adherent care for ovarian cancer: value of an intervention. Gynecol. Oncol. 138, 694–699 (2015).
2. Bristow, R. E. et al. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival. J. Am. Coll. Surg. 220, 940–950 (2015).
3. Schrag, D. et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J. Natl Cancer Inst. 98, 163–171 (2006).
4. Kaufman, B. et al. Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. J. Clin. Oncol. 33, 244–250 (2015).
5. Griffiths, R. W. et al. Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube. Int. J. Gynecol. Cancer 21, 58–65 (2011).
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1/Wnt/β-catenin signaling;iScience;2024-03
2. LncRNA PART1 Regulates Ovarian Carcinoma Development via the miR-150-5p/MYB Axis;Frontiers in Bioscience-Landmark;2023-10-27
3. A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy;JCI Insight;2022-11-22
4. Preclinical In Silico Evidence Indicates the Pharmacological Targets and Mechanisms of Mogroside V in Patients With Ovarian Cancer and Coronavirus Disease 2019;Frontiers in Endocrinology;2022-04-06
5. Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion;Cell Death & Disease;2022-01-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3